Accordingly, our approach emphasizes contextual interpretation of PTH; correction of symptomatic hypocalcemia, hyperphosphatemia, and hypomagnesemia; and avoidance of iatrogenic extremes of calcium load and PTH suppression, alongside selective use of genetics for PFBC. The gene discussed is PTH; the disease is hyperphosphatemia.